16th Jan 2014 07:00
Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
Notice of Announcement of 2013 Final Results
London: Thursday, 16 January 2014: Chi-Med will be announcing its final results for the year ended 31 December 2013 on Tuesday, 18 February 2014. An analyst presentation will be held at 9:00am on the same day at Panmure Gordon, 3rd Floor, One New Change, London, EC4M 9AF.
Ends
Enquiries
Chi-Med Christian Hogg, CEO | Telephone: +852 2121 8200
|
Panmure Gordon (UK) Limited | Telephone: +44 20 7886 2500 |
Richard Gray Andrew Potts Grishma Patel |
|
Citigate Dewe Rogerson Anthony Carlisle David Dible | Telephone: +44 20 7638 9571 Mobile: +44 7973 611 888 Mobile: +44 7967 566 919 |
About Chi-Med
Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited. For more information, please visit: www.chi-med.com.
Related Shares:
Hutchmed